Arvee Laboratories (India) Ltd (ARVEE) is currently trading at 178.58 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Arvee Laboratories (India) Limited is a publicly listed manufacturer of specialty chemicals headquartered in Ahmedabad, Gujarat, with established plants for thiophene derivatives and nitro/sulfo derivatives. The company performs chemical processes including nitration, sulfonation, reduction, esterification, Hoffman reaction and caustic fusion, and has been under current promoter management since 2013. Financials for the quarter and nine months to December 31, 2025 show quarterly revenue of Rs. 991.60 lakh and nine-month revenue of Rs. 2,124.48 lakh, with profit for the quarter reported at Rs. 182.69 lakh and nine-month profit at Rs. 200.61 lakh. Results were approved by the Board and subject to a limited review by the statutory auditors. Operations are reported across two reportable segments: Textile and Non‑Textile. Segment capital employed totals Rs. 3,385.19 lakh, with the Non‑Textile segment carrying larger capital employed (Rs. 2,250.78 lakh) and appearing central to the company’s asset base and production focus. Corporate governance notes: the company has no subsidiaries, consolidated results are not applicable, paid‑up equity is reported as Rs. 1,102.00 lakh, and interim results are prepared under Ind AS with a limited review performed by auditors, reflecting compliance with listing and accounting requirements.

Over the past 52 weeks, Arvee Laboratories (India) Ltd has traded between a low of ₹129.11 and a high of ₹290.78. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Arvee Laboratories (India) Ltd has a market capitalization of approximately 196.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Arvee Laboratories (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 48.59 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 196.80 Cr, Arvee Laboratories (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Arvee Laboratories (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Arvee Laboratories (India) Ltd is 48.59. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.